vs
e.l.f. Beauty, Inc.（ELF）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是e.l.f. Beauty, Inc.的1.3倍（$622.0M vs $489.5M），Royalty Pharma plc净利率更高（34.4% vs 8.0%，领先26.4%），e.l.f. Beauty, Inc.同比增速更快（37.8% vs 4.8%）
e.l.f. Beauty是美国知名彩妆品牌，2004年创立，总部位于加利福尼亚州奥克兰。品牌产品线丰富，涵盖沐浴护肤产品、矿物彩妆、专业美妆工具、眼线笔、口红、腮红、睫毛膏等多个品类，产品销往全球18个国家，入驻Target、沃尔玛等主流零售渠道，过半营收来自品牌官网。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ELF vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.3倍
$489.5M
营收增速更快
ELF
高出33.0%
4.8%
净利率更高
RPRX
高出26.4%
8.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $489.5M | $622.0M |
| 净利润 | $39.4M | $214.2M |
| 毛利率 | 71.0% | — |
| 营业利润率 | 13.8% | 62.4% |
| 净利率 | 8.0% | 34.4% |
| 营收同比 | 37.8% | 4.8% |
| 净利润同比 | 128.1% | 2.9% |
| 每股收益（稀释后） | $0.65 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELFRPRX
| Q4 25 | $489.5M | $622.0M | ||
| Q3 25 | $343.9M | $609.3M | ||
| Q2 25 | $353.7M | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | — | $593.6M | ||
| Q3 24 | — | $564.7M | ||
| Q2 24 | — | $537.3M | ||
| Q1 24 | — | $568.0M |
净利润ELFRPRX
| Q4 25 | $39.4M | $214.2M | ||
| Q3 25 | $3.0M | $288.2M | ||
| Q2 25 | $33.3M | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | — | $544.0M | ||
| Q2 24 | — | $102.0M | ||
| Q1 24 | — | $4.8M |
毛利率ELFRPRX
| Q4 25 | 71.0% | — | ||
| Q3 25 | 69.4% | — | ||
| Q2 25 | 69.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ELFRPRX
| Q4 25 | 13.8% | 62.4% | ||
| Q3 25 | 2.2% | 70.1% | ||
| Q2 25 | 13.8% | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率ELFRPRX
| Q4 25 | 8.0% | 34.4% | ||
| Q3 25 | 0.9% | 47.3% | ||
| Q2 25 | 9.4% | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | — | 96.3% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）ELFRPRX
| Q4 25 | $0.65 | $0.49 | ||
| Q3 25 | $0.05 | $0.67 | ||
| Q2 25 | $0.58 | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.8M | $618.7M |
| 总债务越低越好 | $816.7M | $9.0B |
| 股东权益账面价值 | $1.2B | $9.7B |
| 总资产 | $2.3B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.70× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ELFRPRX
| Q4 25 | $196.8M | $618.7M | ||
| Q3 25 | $194.4M | $938.9M | ||
| Q2 25 | $170.0M | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务ELFRPRX
| Q4 25 | $816.7M | $9.0B | ||
| Q3 25 | $831.6M | $8.9B | ||
| Q2 25 | $256.7M | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益ELFRPRX
| Q4 25 | $1.2B | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $804.9M | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产ELFRPRX
| Q4 25 | $2.3B | $19.6B | ||
| Q3 25 | $2.3B | $19.3B | ||
| Q2 25 | $1.3B | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | — | $18.2B | ||
| Q3 24 | — | $18.0B | ||
| Q2 24 | — | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比ELFRPRX
| Q4 25 | 0.70× | 0.92× | ||
| Q3 25 | 0.73× | 0.93× | ||
| Q2 25 | 0.32× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $52.8M | — |
| 自由现金流率自由现金流/营收 | 10.8% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 1.51× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ELFRPRX
| Q4 25 | $59.4M | $827.1M | ||
| Q3 25 | $23.4M | $702.6M | ||
| Q2 25 | $27.2M | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | — | $742.5M | ||
| Q3 24 | — | $703.6M | ||
| Q2 24 | — | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流ELFRPRX
| Q4 25 | $52.8M | — | ||
| Q3 25 | $16.6M | — | ||
| Q2 25 | $20.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ELFRPRX
| Q4 25 | 10.8% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ELFRPRX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ELFRPRX
| Q4 25 | 1.51× | 3.86× | ||
| Q3 25 | 7.82× | 2.44× | ||
| Q2 25 | 0.82× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELF
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
